Chardan Capital Maintains Krystal Biotech (KRYS) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on May 22, 2023, Chardan Capital maintained coverage of Krystal Biotech (NASDAQ:KRYS) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-722208811-b3d22c5e5c164942a1983f328bfe06be.jpg "How to Become a Retirement Super Saver")